OR WAIT null SECS
© 2023 MJH Life Sciences and Consultant Live. All rights reserved.
Granite Bay, California
November 24, 2023
Retina specialists highlight the safety data of both faricimab and high-dose aflibercept for use in treating nAMD and DME.
M. Ali Khan, MD, FACS, FASRS, reviews the PULSAR and PHOTON clinical trials of high-dose aflibercept for treatment of nAMD and DME.
November 17, 2023
Drs Rishi P. Singh and M. Ali Khan review the real-world experience of using faricimab to treat nAMD and DME, as well as its durability compared to clinical trials.
Rishi P. Singh, MD, and M. Ali Khan, MD, FACS, FASRS, discuss the need for extending treatment durability for neovascular age-related macular degeneration [nAMD] and diabetic macular edema [DME], as well as approaches to applying treat-and-extend strategies.